-+ 0.00%
-+ 0.00%
-+ 0.00%

Iridex Lowers FY2026 Sales Guidance from $51.000M-$53.000M to $46.000M-$48.000M vs $52.521M Est

Benzinga·11/17/2026 21:05:42
Listen to the news
Iridex (NASDAQ:IRIX) lowers FY2026 sales outlook from $51.000 million-$53.000 million to $46.000 million-$48.000 million vs $52.521 million estimate.